UBS analyst Chris Snyder upgrades Trane Technologies (NYSE:TT) from Neutral to Buy and raises the price target from $168 to $200.
Evaluating Guardant Health: Insights From 5 Financial Analysts
In the preceding three months, 5 analysts have released ratings for Guardant Health (NASDAQ:GH), presenting a wide array…